Résumé
RESUMEN Introducción: El síndrome Schaaf Yang (SHFYNG) constituye un desorden multisistémico caracterizado por un grupo de signos y síntomas relacionados con alteraciones genéticas, congénitas y de expresión clínica multivariable. Fue descrito por primera vez por el Dr. Schaaf y la Dra. Yaping, profesores de Genética Molecular y Humana de la Universidad de Houston y Baylor, respectivamente, en 2013 (1). El síndrome SHFYNG tiene una herencia autosómica dominante con una mutación presente en el alelo paterno, ya que el gen MA-GEL2 tiene una impronta materna y solo se expresa el alelo paterno. A diferencia de otras patologías autosómicas dominantes clásicas, el síndrome SHFYNG puede saltar varias generaciones siempre que la mutación resida en el cromosoma materno. Presentación del caso. Preescolar femenina, con antecedente de estancia en UCIN por hipotonía neonatal y pobre succión, bronquitis y neumonía. Su fenotipo está caracterizado por facies hipotónicas, frente prominente, epicanto interno, pómulos prominentes, puente nasal bajo, nariz ancha, labio superior delgado, orejas aladas, cuello corto y obesidad central. Presenta retraso en el neurodesarrollo, lenguaje y psicomotor. Estudios genéticos: cariotipo 46,XX e hibridación genómica comparativa con patrón genómico normal, sexo femenino, en exoma trío se identifica una variante patogénica: c.1996dupC (p.Gln666Profs*47) en el gen MAGEL2 asociada con SHFYNG. Conclusión. Se informa el primer reporte de este síndrome a nivel nacional con una incidencia mundial muy baja, estimándose aproximadamente <1/1.000.000 de nacidos vivos, lo que permite ampliar el conocimiento y sospechar patologías de difícil diagnóstico como esta.
ABSTRACT Introduction: Schaaf Yang Syndrome (SHFYNG) is a multisystemic disorder characterized by a group of signs and symptoms related to genetic, congenital, and multivariate clinical alterations. It was first described by Dr. Schaaf and Dr. Yaping, professors of Molecular and Human Genetics at the University of Houston and Baylor, respectively, in 2013 (1). SHFYNG has an autosomal dominant inheritance with a mutation located in the paternal allele, since the MAGEL2 gene has a maternal imprint and only the paternal allele is expressed. Unlike other classic autosomal dominant pathologies, SHFYNG syndrome can skip several generations, as long as the mutation resides on the maternal chromosome. Presentation of the case: Female preschooler, with a history of stay in the Neonatal Intensive Care Unit, due to neonatal hypotonia and poor suction, bronchitis, and pneumonia. Her phenotype is distinguished by hypotonic facies, prominent forehead, internal epican-thus, prominent cheekbones, low nasal bridge, broad nose, thin upper lip, winged ears, short neck, and central obesity. She presents neurodevelopmental, language, and psychomotor delay. Genetic studies: 46,XX karyotype, comparative genomic hybridization: normal genomic pattern, female sex, trio exam a pathogenic variant c.1996dupC (p.Gln666Profs*47) in the MAGEL2 gene associated with SHFYNG syndrome. Conclusion: It is reported to be the first national report of this syndrome, with a very low worldwide incidence, estimating approximately <1 / 1,000,000 live births, which allows us to expand knowledge and suspect difficult-to-diagnose pathologies like this one.
Résumé
OBJECTIVES: Conflicting data from studies on the potential role of multidrug resistance 1 gene polymorphisms in inflammatory bowel disease may result from the analysis of genetically and geographically distinct populations. Here, we investigated whether multidrug resistance 1 gene polymorphisms are associated with inflammatory bowel diseases in patients from Rio de Janeiro. METHODS: We analyzed 123 Crohn's disease patients and 83 ulcerative colitis patients to determine the presence of the multidrug resistance 1 gene polymorphisms C1236T, G2677T and C3435T. In particular, the genotype frequencies of Crohn's disease and ulcerative colitis patients were analyzed. Genotype-phenotype associations with major clinical characteristics were established, and estimated risks were calculated for the mutations. RESULTS: No significant difference was observed in the genotype frequencies of the multidrug resistance 1 G2677T/A and C3435T polymorphisms between Crohn's disease and ulcerative colitis patients. In contrast, the C1236T polymorphism was significantly more common in Crohn's disease than in ulcerative colitis (p = 0.047). A significant association was also found between the multidrug resistance 1 C3435T polymorphism and the stricturing form of Crohn's disease (OR: 4.13; p = 0.009), whereas no association was found with penetrating behavior (OR: 0.33; p = 0.094). In Crohn's disease, a positive association was also found between the C3435T polymorphism and corticosteroid resistance/refractoriness (OR: 4.14; p = 0.010). However, no significant association was found between multidrug resistance 1 gene polymorphisms and UC subphenotypic categories. CONCLUSION: The multidrug resistance 1 gene polymorphism C3435T is associated with the stricturing phenotype and an inappropriate response to therapy in Crohn's disease. This association with Crohn's disease may support additional pathogenic roles ...